Xarelto Lawsuit Alleges That Drug Manufacturers Are Liable For Wife’s Life-Threatening Injuries

January 14, 2016 – – BloodThinnerHelp.com reports on a lawsuit filed against Xarelto manufacturers Bayer AG and Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson corporation). The lawsuit alleges that their blood thinning drug, Xarelto, caused the wife, an Ohio resident, to suffer from serious and life-threatening bleeding injuries. Together, the husband and wife pair are now requesting in excess of $150,000 in compensation for mounting medical bills, future medical bills, and pain and suffering.

Details found within the court documents indicate that the plaintiff involved was prescribed Xarelto (rivaroxaban) by her family physician in order to treat a common heart condition known as atrial fibrillation which can cause strokes. The medication was taken as a preventative measure to avoid these strokes, however, the couple states, the wife ended up suffering from something just as serious.

Just two months after beginning to use Xarelto, the woman suddenly suffered from severe gastrointestinal bleeding, and anemia, as well as multiple other injuries that were not detailed but are said to be long-lasting health problems. Still today, the woman requires medical treatments and says that she is no longer able to enjoy life as she used to.

Xarelto was approved by the U.S. Food and Drug Administration as a new type of anticoagulant. It was intended to help reduce the risk of blood clots for individuals recovering from hip and knee replacement surgeries, as well as reducing the risk of stroke for those with atrial fibrillation.

After its initial market launch, Xarelto has quickly become the topic of almost 3,000 lawsuits filed across the United States, which commonly allege that the drug causes patients an increased risk of uncontrollable bleeding episodes, some of which could prove fatal.

Federally filed Xarelto lawsuits have been consolidated by the JPML to form multidistrict litigation number 2592. They are being overseen in the Eastern District of Louisiana. This case, as well, is expected be transferred there for pretrial proceedings.

As these cases await trial, many anticipate that others will continue to join them. Attorney Joseph Osborne is now working to help anyone who may have been negatively affected by Xarelto but who has not yet filed a lawsuit. These individuals may be entitled to legal action and substantial compensation. Those involved are encouraged to fully explore their legal options, and are currently offered free consultations by Attorney Osborne.

To request further information or ask questions, please contact Joseph Osborne, Esq., by calling (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Joseph Osborne
866-425-8902
Mizner Park
433 Plaza Real Blvd., Ste. 271
Boca Raton, FL 33432

ReleaseID: 60007233